Valeant to be led by group of senior execs as CEO on medical leave
Dec 28 (Reuters) - Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.
Pearson will be on a medical leave of absence, effective immediately, the company said in a statement on Monday.
Pearson was hospitalized with a "severe case of pneumonia" on Friday and is receiving treatment, a company spokeswoman said on Friday.
Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial officer Robert Rosiello. (Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)
© Thomson Reuters 2017 All rights reserved.